Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹37Cr
Rev Gr TTM
Revenue Growth TTM
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

UNILEX
VS
| Quarter | Mar 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | | | -15.9 |
| 75 | 72 | 66 |
Operating Profit Operating ProfitCr |
| 4.4 | 1.2 | 0.2 |
Other Income Other IncomeCr | 3 | 3 | 3 |
Interest Expense Interest ExpenseCr | 1 | 1 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 |
| 6 | 3 | 2 |
| 1 | 1 | 0 |
|
Growth YoY PAT Growth YoY% | | | -64.4 |
| 5.3 | 3.0 | 2.3 |
| 0.0 | 1.9 | 1.1 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 61.1 | -4.0 | 3.2 | 5.3 | -8.3 |
| 84 | 144 | 136 | 139 | 147 | 138 |
Operating Profit Operating ProfitCr |
| 6.4 | 0.9 | 2.1 | 3.1 | 2.8 | 0.7 |
Other Income Other IncomeCr | 2 | 6 | 5 | 5 | 6 | 6 |
Interest Expense Interest ExpenseCr | 0 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 0 | 1 | 1 | 1 | 1 | 1 |
| 7 | 6 | 7 | 8 | 9 | 6 |
| 2 | 2 | 2 | 2 | 2 | 1 |
|
| | -6.9 | 5.5 | 24.1 | 4.0 | -42.1 |
| 5.6 | 3.2 | 3.6 | 4.3 | 4.2 | 2.7 |
| 10.1 | 4.7 | 5.0 | 6.2 | 5.4 | 3.0 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Equity Capital Equity CapitalCr | 3 | 3 | 3 | 10 | 14 |
| 21 | 25 | 29 | 27 | 58 |
Current Liabilities Current LiabilitiesCr | 36 | 48 | 38 | 53 | 29 |
Non Current Liabilities Non Current LiabilitiesCr | 1 | 0 | 1 | 1 | 1 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 50 | 65 | 59 | 79 | 95 |
Non Current Assets Non Current AssetsCr | 11 | 12 | 12 | 12 | 7 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 1 | -6 | 2 | -4 | -1 |
Investing Cash Flow Investing Cash FlowCr | -1 | -1 | -1 | 0 | 6 |
Financing Cash Flow Financing Cash FlowCr | 2 | 3 | -1 | 8 | 21 |
|
Free Cash Flow Free Cash FlowCr | 0 | -6 | 2 | -5 | 4 |
| 24.4 | -117.5 | 47.0 | -66.2 | -12.5 |
CFO To EBITDA CFO To EBITDA% | 21.4 | -437.9 | 80.0 | -92.4 | -18.6 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 0 | 65 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 10.1 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 |
| 0.5 | 8.5 | 3.6 | 3.9 | 11.6 |
Profitability Ratios Profitability Ratios |
| 18.5 | 8.2 | 10.6 | 11.6 | 14.6 |
| 6.4 | 0.9 | 2.1 | 3.1 | 2.8 |
| 5.6 | 3.2 | 3.6 | 4.3 | 4.2 |
| 23.0 | 17.8 | 16.9 | 15.9 | 11.5 |
| 20.9 | 16.8 | 15.5 | 16.7 | 9.0 |
| 8.3 | 6.1 | 7.0 | 6.8 | 6.3 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Unilex Colours and Chemicals Limited is a prominent Indian manufacturer and trader of pigments, food colours, and specialized chemicals. Operating as a **Govt. Recognised Three Star Export House**, the company has established a significant global footprint, providing high-performance colorant solutions to industries including plastics, rubber, textiles, printing inks, and consumer goods.
---
### **Core Business Architecture: Manufacturing vs. Trading**
The company operates through a dual-model approach, balancing specialized in-house production with a broad-based trading portfolio to serve as a one-stop solution for industrial colorants.
* **Manufacturing Excellence:** Under the registered brand **'Unilex'**, the company specializes in the production of **Pigment Blue 15:3** and **15:4**. These are high-demand organic pigments known for their stability and brilliance in ink and plastic applications.
* **Comprehensive Trading Portfolio:** To complement its manufactured range, Unilex sources and distributes a wide array of third-party products:
* **Industrial Pigments:** Including Pigment Green 7, Middle Chrome, Lemon Chrome, Pigment Violet (3, 23, 27), Ultramarine Blue, and various Azo pigments (Red, Orange, Yellow).
* **Food Colours:** A specialized range including Tartrazine, Sunset Yellow, Allura Red, Ponceau 4R, Carmoisine, and Brilliant Blue.
#### **Revenue Mix Analysis**
While total revenue has grown, the contribution from the manufacturing segment has seen a strategic shift as the company expands its trading and distribution reach:
| Fiscal Year | Manufacturing Revenue (₹ Crore) | % of Total Revenue |
| :--- | :---: | :---: |
| **FY 2024** | **66.52** | **46.24%** |
| **FY 2023** | **74.55** | **53.48%** |
| **FY 2022** | **84.88** | **58.42%** |
---
### **Industrial Infrastructure & Technical Compliance**
Unilex operates a centralized, high-standard manufacturing facility in Maharashtra, designed for scalability and international regulatory adherence.
| Feature | Details |
| :--- | :--- |
| **Location** | MIDC - Tarapur, Boisar, Palghar, Maharashtra |
| **Facility Area** | Approximately **1,275 sq. meters** |
| **Annual Production Capacity** | **1,878 MTPA** |
| **Key Equipment** | Ball Mill Machines, Reaction Steel Vessels, Spin Flash Dryers, Air Classifier Mills, and Filter Press Machines |
| **Certifications** | **ISO 9001:2015** and **REACH Registration** (Essential for EU market access) |
The facility integrates **Process Automation** to minimize human error and utilizes energy-efficient equipment to maintain a lean cost structure, ensuring that energy expenses remain a minimal portion of total overheads.
---
### **Specialized Diversification: Oral Healthcare & R&D**
Beyond industrial pigments, Unilex has diversified into the high-margin **Oral Healthcare** sector. This division is supported by an in-house **Research and Development (R&D) Centre** located at the primary manufacturing unit.
* **Product Categories:**
* **Dental Materials:** Specialized supplies for clinical dental procedures.
* **Oral Care Products:** Consumer-facing hygiene and preventative care formulations.
* **R&D Objectives:** The center focuses on **lab-scale development**, enhancing **product stability**, and ensuring all new formulations meet rigorous international safety and performance standards.
---
### **Strategic Growth: Acquisitions & Capital Markets**
Unilex has transitioned toward an inorganic growth model to strengthen its supply chain and market dominance.
* **Inorganic Expansion:** In **January 2026**, the company acquired a **60% stake** in **Unisynth Overseas Limited** for a total consideration of **₹6,69,19,710**. This involved the subscription of **24,63,000 equity shares** at **₹27.17 per share**, aimed at enhancing market reach in the coatings and inks industries.
* **Public Listing:** The company successfully tapped the capital markets in late 2024 to fund its expansion.
| Event | Details |
| :--- | :--- |
| **Listing Date** | **October 03, 2024** |
| **Platform** | **NSE Emerge (SME Platform)** |
| **Total Funds Raised** | **₹31.32 Crore** |
| **Issue Price** | **₹87 per share** (Face Value: **₹10**) |
---
### **Global Reach & Logistics Capabilities**
Unilex maintains an active presence in over **14 countries**, including **Vietnam, Brazil, Mexico, Russia, Turkey, Netherlands, Poland, China, Spain, and the UAE**.
* **Logistics Excellence:** The company offers versatile packaging solutions to meet international shipping standards, including **Multi-Layer Paper Bags**, **HDPE Coated Bags**, **Jumbo Bags**, and **Wooden Pallets**.
* **Market Entry:** Growth is driven by direct marketing and consistent participation in international trade exhibitions and conferences.
---
### **Financial Performance Summary**
The company has demonstrated a trajectory of steady growth in both top-line revenue and bottom-line profitability.
| Metric (in ₹ Crore) | FY 2024-25 | FY 2023-24 | Growth (%) |
| :--- | :--- | :--- | :--- |
| **Revenue from Operations** | **157.81** | **149.33** | **5.68%** |
| **Net Profit** | **6.41** | **6.17** | **3.89%** |
---
### **Risk Management & Competitive Positioning**
Unilex operates in a highly competitive landscape, facing large-scale peers such as **Sudarshan Chemical Industries Limited** and **Kesar Petroproducts Limited**. To mitigate risks, the company employs a structured **Business Risk Management** framework focusing on:
* **Supply Chain Resilience:** Onboarding **new suppliers** and restructuring procurement to counter volatile raw material costs.
* **Regulatory Adherence:** Maintaining strict **Safety, Health, and Environmental (SHE)** standards and **REACH** compliance to protect export revenues.
* **Operational Efficiency:** Continuous focus on cost reduction in production and distribution to protect margins against rising global freight expenses and softening demand.
* **Governance:** The appointment of **Independent Directors** ensures high standards of transparency and ethical conduct as a listed entity.